MedPath

Peri-operative Vitamin D Therapy for Hepatectomy

Not Applicable
Not yet recruiting
Conditions
Hepatocellular Carcinoma
Vitamin D Deficiency
Perioperative Complication
Registration Number
NCT05650151
Lead Sponsor
National Taiwan University Hospital
Brief Summary

The goal of this double-blind, randomized controlled trial is to test the effect of short-term and high-dose vitamin D therapy in patients undergoing hepatectomy for hepatocellular carcinoma.

Detailed Description

Participants will receive short-term high dose of vitamin D during perioperative period.

The main questions the study aims to answer are:

1. If vitamin D therapy benefits perioperative care

2. If short-term high dose of vitamin D supplement is safe

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients older than 20 years
  • Patients will undergo hepatectomy for hepatocellular carcinoma.
Exclusion Criteria
  • Patients with hypercalcemia, hyperparathyroidism, sarcoidosis, multiple myeloma

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Infection ratePerioperative period

Diagnosed by clinical presentation and relevant biomarker

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.